SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030121
Filing Date
2019-08-07
Accepted
2019-08-07 16:30:20
Documents
54
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrca-10q_20190630.htm 10-Q 1974007
2 EX-31.1 vrca-ex311_6.htm EX-31.1 15036
3 EX-31.2 vrca-ex312_8.htm EX-31.2 14971
4 EX-32.1 vrca-ex321_7.htm EX-32.1 11192
  Complete submission text file 0001564590-19-030121.txt   6234852

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrca-20190630.xml EX-101.INS 1406108
6 XBRL TAXONOMY EXTENSION SCHEMA vrca-20190630.xsd EX-101.SCH 33998
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrca-20190630_cal.xml EX-101.CAL 40488
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrca-20190630_def.xml EX-101.DEF 110415
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20190630_lab.xml EX-101.LAB 299432
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20190630_pre.xml EX-101.PRE 222725
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38529 | Film No.: 191005904
SIC: 2834 Pharmaceutical Preparations